Wang Chen, Chen Xiaoyan, Chen Xin, He Yihui, Cao Liyu
Department of Pathology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou 350001, China.
Department of Pathology, the First Affiliated Hospital of Anhui Medical University, Hefei 230032, China; E-mail:
Zhonghua Bing Li Xue Za Zhi. 2015 Aug;44(8):565-70.
To study the role of microRNAs (miRNAs) in ALK-negative anaplastic large cell lymphoma and CD30 positive peripheral T cell lymphoma (not otherwise specified), and discuss the pathogenesis of miRNAs in ALK-negative anaplastic large cell lymphoma.
Three cases of ALK-negative anaplastic large cell lymphoma of lymph node, 3 cases of CD30-positive peripheral T cell lymphoma (not otherwise specified) of lymph node and 3 cases of reactive hyperplasia of lymph node were detected by high flow microarray of miRNAs. The method of real-time quantitative polymerase chain reaction was further applied for 7 miRNAs in 15 cases of ALK-negatie anaplastic large cell lymphomas of lymph node and 15 cases of CD30-positive peripheral T cell lymphoma (not otherwise specified) of lymph node.
The significant difference of 13 miRNAs was found between ALK-negative anaplastic large cell lymphoma and CD30 positive peripheral T cell lymphoma (not otherwise specified) (P < 0.05), of which the result of 5 miRNAs was consistent with miRNAs expression spectrum: miR-664b-5p, miR-1275, miR-4739, miR-4736 and miR-504-5p, the difference was statistically significant (P < 0.05). Compared with reactive hyperplasia of lymph nodes, miR-664b-5p, miR-1275 and miR-4739 were significantly under-expressed (P = 0.004, P = 0.021, P = 0.031) and miR-4736 and miR-504-5p were significantly over-expressed (P = 0.009, P = 0.007) in ALK negative anaplastic large cell lymphoma.
MiR-664b-5p, miR-1275, miR-4739, miR-4736 and miR-504-5p may become an important indicator in the differentiation ALK-negative anaplastic large cell lymphoma from CD30-positive peripheral T cell lymphoma (not otherwise specified). MiR-4739, miR-4736 and miR-1275 may play important role in pathogenesis of negative-anaplastic large cell lymphoma by target genes: TNFRSF8 and TMOD1.
研究微小RNA(miRNA)在ALK阴性间变性大细胞淋巴瘤及CD30阳性外周T细胞淋巴瘤(非特指型)中的作用,并探讨miRNA在ALK阴性间变性大细胞淋巴瘤中的发病机制。
采用miRNA高通量芯片检测3例淋巴结ALK阴性间变性大细胞淋巴瘤、3例淋巴结CD30阳性外周T细胞淋巴瘤(非特指型)及3例淋巴结反应性增生组织。进一步应用实时定量聚合酶链反应方法检测15例淋巴结ALK阴性间变性大细胞淋巴瘤及15例淋巴结CD30阳性外周T细胞淋巴瘤(非特指型)中的7种miRNA。
ALK阴性间变性大细胞淋巴瘤与CD30阳性外周T细胞淋巴瘤(非特指型)之间有13种miRNA存在显著差异(P<0.05),其中5种miRNA的结果与miRNA表达谱一致:miR-664b-5p、miR-1275、miR-4739、miR-4736和miR-504-5p,差异具有统计学意义(P<0.05)。与淋巴结反应性增生相比,ALK阴性间变性大细胞淋巴瘤中miR-664b-5p、miR-1275和miR-4739显著低表达(P=0.004、P=0.021、P=0.031),miR-4736和miR-504-5p显著高表达(P=0.009、P=0.007)。
MiR-664b-5p、miR-1275、miR-4739、miR-4736和miR-504-5p可能成为鉴别ALK阴性间变性大细胞淋巴瘤与CD30阳性外周T细胞淋巴瘤(非特指型)的重要指标。MiR-4739、miR-4736和miR-1275可能通过靶基因TNFRSF8和TMOD1在阴性间变性大细胞淋巴瘤发病机制中发挥重要作用。